Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows. Semaglutide (also known as Ozempic), ...

Everyone has been talking about Ozempic in recent years. You may have seen the name in the news or even know someone who is taking this blockbuster drug. Though Ozempic, made by Novo Nordisk, is ...

Add Yahoo as a preferred source to see more of our stories on Google. IN 2002, NOVO Nordisk chemists Thomas Kruse and Jesper Lau were studying small molecules in the global pharmaceutical company’s ...

GLP-1 drugs show promise for more than weight loss. They also cut substance abuse and are changing how we think about the ...

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. While providers may prescribe this drug off label ...

India emerges as key battleground for GLP-1 drugs Novo races to counter Lilly's Mounjaro in India Generics loom as semaglutide patent expiry nears in 2026 HYDERABAD, India, Dec 3 (Reuters) - Danish ...

For many people, the thought of a tasty burger or a cold pint of beer conjures a vivid mental image and drives behavior. This link between thinking and doing serves a clear function—it motivates us to ...